Filing Details

Accession Number:
0001179110-17-015677
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-19 19:07:20
Reporting Period:
2017-12-15
Accepted Time:
2017-12-19 19:07:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1113481 Medicines Co MDCO Pharmaceutical Preparations (2834) 043324394
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204787 Clive Meanwell 8 Sylvan Way
Parsippany NJ 07054
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-12-15 200,920 $19.36 587,652 No 4 M Direct
Common Stock Disposition 2017-12-15 136,250 $27.24 451,402 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right-to-buy) Disposition 2017-12-15 200,920 $0.00 200,920 $19.36
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-02-15 No 4 M Direct
Footnotes
  1. Represents the weighted average sales price of the shares sold ranging from a low of $27.20 to a high of $27.51 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  2. As a result of Dr. Meanwell's option exercise and purchase of a portion of the underlying shares as reported on this Form 4, Dr. Meanwell holds an additional 64,670 shares of common stock.
  3. This option vested in forty eight equal installments beginning on March 15, 2008.
  4. Options exercised due to their near term expiry.
  5. Not applicable.